3D-Structure of Protein Revealed, Studied As Link to Early Onset of Parkinson’s
Researchers have discovered the 3D structure of a protein involved in inflammation, with implications in developing future treatments for Parkinson’s…
Patricia holds her PhD in cell biology from the University Nova de Lisboa, Portugal, and has served as an author on several research projects and fellowships, as well as major grant applications for European agencies. She also served as a PhD student research assistant in the Department of Microbiology & Immunology, Columbia University, New York, for which she was awarded a Luso-American Development Foundation (FLAD) fellowship.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Researchers have discovered the 3D structure of a protein involved in inflammation, with implications in developing future treatments for Parkinson’s…
Electrical-pulse brain stimulation eases a common mobility problem that Parkinson’s patients face — their walk freezing in mid-step, a study…
A second group of Parkinson’s patients in a Phase 1 clinical trial have received International Stem Cell Corporation’s neural stem cell…
The Parkinson’s Foundation is establishing a new program offering genetic testing and counseling to Parkinson’s patients within its Centers of…
University of Pennsylvania researchers used a new technology that mimics the way animated movies capture a person’s movement to…
People with Parkinson’s disease are being recruited for a new clinical trial testing nilotinib, an FDA-approved leukemia treatment, in a…
New technology that uses MRI-guided focused ultrasound to target areas of the brain affected by Parkinson’s disease and improve…
Cardiolipin, a molecule inside nerve cells, may be a key player behind nerve cell death in Parkinson’s disease, a study…
Genervon Biopharmaceuticals announced its future goals for investigational therapy GM6 in a recent presentation on its multi-target drug development…
Mutations in mitochondria, which result in a shortage of energy, may be an underlying cause of movement difficulties associated with…
Get regular updates to your inbox.